Effect of Written Exposure Therapy vs Cognitive Processing Therapy on Increasing Treatment Efficiency Among Military Service Members With Posttraumatic Stress Disorder: A Randomized Noninferiority Trial

Denise M Sloan, Brian P Marx, Patricia A Resick, Stacey Young-McCaughan, Katherine A Dondanville, Casey L Straud, Jim Mintz, Brett T Litz, Alan L Peterson, STRONG STAR Consortium, Denise M Sloan, Brian P Marx, Patricia A Resick, Stacey Young-McCaughan, Katherine A Dondanville, Casey L Straud, Jim Mintz, Brett T Litz, Alan L Peterson, STRONG STAR Consortium

Abstract

Importance: Posttraumatic stress disorder (PTSD) occurs more commonly among military service members than among civilians; however, despite the availability of several evidence-based treatments, there is a need for more efficient evidence-based PTSD treatments to better address the needs of service members. Written exposure therapy is a brief PTSD intervention that consists of 5 sessions with no between-session assignments, has demonstrated efficacy, and is associated with low treatment dropout rates, but prior randomized clinical trials of this intervention have focused on civilian populations.

Objective: To investigate whether the brief intervention, written exposure therapy, is noninferior in the treatment of PTSD vs the more time-intensive cognitive processing therapy among service members diagnosed with PTSD.

Design, setting, and participants: The study used a randomized, noninferiority design with a 1:1 randomization allocation. Recruitment for the study took place from August 2016 through October 2020. Participants were active-duty military service members diagnosed with posttraumatic stress disorder. The study was conducted in an outpatient setting for service members seeking PTSD treatment at military bases in San Antonio or Killeen, Texas.

Interventions: Participants received either written exposure therapy, which consisted of 5 weekly sessions, or cognitive processing therapy, which consisted of 12 twice-weekly sessions.

Main outcomes and measures: Participants were assessed at baseline and at 10, 20, and 30 weeks after the first treatment session. The primary outcome measure was PTSD symptom severity assessed with the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5). Noninferiority was defined as the difference between the 2 groups being less than the upper bound of the 1-sided 95% CI-specified margin of 10 points on the CAPS-5.

Results: Overall, 169 participants were included in the study. Participants were predominantly male (136 [80.5%]), serving in the Army (167 [98.8%]), with a mean (SD) age of 34 (8) years. Eighty-five participants were randomly assigned to written exposure therapy, with 65 (76.5%) completing all treatment sessions, and 84 to cognitive processing therapy, with 47 (54.8%) completing all treatment sessions. Findings indicated that written exposure therapy was noninferior to cognitive processing therapy, with the largest difference in change in outcome between the treatment conditions of 3.96 points on the outcome measure. The 1-sided 95% CI upper limit was less than 10 points across time points in both groups and ranged from 4.59 at week 30 to 6.81 at week 10. Within-condition effect sizes ranged from a Cohen d of 0.48 for the written exposure therapy group in the intention-to-treat analysis at week 10 to 0.95 for the cognitive processing therapy group in the per-protocol analysis at week 10, and between-condition effect size ranged from 0.06 in the intention-to-treat analysis at week 30 to 0.22 in the per-protocol analysis at week 10.

Conclusions and relevance: In this randomized clinical trial, support was found for an effective and more efficient PTSD treatment approach for service members. Future research should determine who does and does not benefit from PTSD treatment to best maximize treatment outcomes.

Trial registration: ClinicalTrials.gov Identifier: NCT03033602.

Conflict of interest statement

Conflict of Interest Disclosures: Drs Sloan and Marx reported receiving royalties for the treatment manual for one of the treatments examined in the study from the American Psychological Association during the conduct of the study. Dr Resick reported receiving grants from Duke Health during the conduct of the study and royalties for a cognitive processing therapy published treatment manual from Guilford Press. Dr Young-McCaughan reported receiving grants from the Department of Veterans Affairs outside the submitted work. No other disclosures were reported.

Figures

Figure.. Study Flow Diagram
Figure.. Study Flow Diagram
CPT-C indicates cognitive processing therapy–cognitive therapy only; WET, written exposure therapy.

References

    1. Crum-Cianflone NF, Powell TM, LeardMann CA, Russell DW, Boyko EJ. Mental health and comorbidities in U.S. military members. Mil Med. 2016;181(6):537-545. doi:10.7205/MILMED-D-15-00187
    1. Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. . Trauma and PTSD in the WHO World Mental Health Surveys. Eur J Psychotraumatol. 2017;8(sup5)(suppl 5):1353383. doi:10.1080/20008198.2017.1353383
    1. Foa EB, McLean CP, Zang Y, et al. ; STRONG STAR Consortium . Effect of prolonged exposure therapy delivered over 2 weeks vs 8 weeks vs present-centered therapy on PTSD symptom severity in military personnel: a randomized clinical trial. JAMA. 2018;319(4):354-364. doi:10.1001/jama.2017.21242
    1. Resick PA, Wachen JS, Mintz J, et al. ; STRONG STAR Consortium . A randomized clinical trial of group cognitive processing therapy compared with group present-centered therapy for PTSD among active duty military personnel. J Consult Clin Psychol. 2015;83(6):1058-1068. doi:10.1037/ccp0000016
    1. Resick PA, Wachen JS, Dondanville KA, et al. ; and the STRONG STAR Consortium . Effect of group vs individual cognitive processing therapy in active-duty military seeking treatment for posttraumatic stress disorder: a randomized clinical trial. JAMA Psychiatry. 2017;74(1):28-36. doi:10.1001/jamapsychiatry.2016.2729
    1. Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004;351(1):13-22. doi:10.1056/NEJMoa040603
    1. Watts BV, Schnurr PP, Mayo L, Young-Xu Y, Weeks WB, Friedman MJ. Meta-analysis of the efficacy of treatments for posttraumatic stress disorder. J Clin Psychiatry. 2013;74(6):e541-e550. doi:10.4088/JCP.12r08225
    1. Hoge CW, Grossman SH, Auchterlonie JL, Riviere LA, Milliken CS, Wilk JE. PTSD treatment for soldiers after combat deployment: low utilization of mental health care and reasons for dropout. Psychiatr Serv. 2014;65(8):997-1004. doi:10.1176/appi.ps.201300307
    1. Foa EB, Hembree EA, Rothbaum BO, Rauch SAM. Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences. Therapist Guide. 2nd ed. Oxford University Press; 2019. doi:10.1093/med-psych/9780190926939.001.0001
    1. Resick PA, Monson CM, Chard KM. Cognitive Processing Therapy for PTSD: A Comprehensive Manual. Guilford Press; 2017.
    1. Sloan, DM, Marx, BP. Written Exposure Therapy for PTSD: A Brief Treatment Approach for Mental Health Professionals. American Psychological Press; 2019. doi:10.1037/0000139-000
    1. Sloan DM, Marx BP, Bovin MJ, Feinstein BA, Gallagher MW. Written exposure as an intervention for PTSD: a randomized clinical trial with motor vehicle accident survivors. Behav Res Ther. 2012;50(10):627-635. doi:10.1016/j.brat.2012.07.001
    1. Sloan DM, Marx BP, Lee DJ, Resick PA. A brief exposure-based treatment vs cognitive processing therapy for posttraumatic stress disorder: a randomized noninferiority clinical trial. JAMA Psychiatry. 2018;75(3):233-239. doi:10.1001/jamapsychiatry.2017.4249
    1. Resick PA, Galovski TE, Uhlmansiek MO, Scher CD, Clum GA, Young-Xu Y. A randomized clinical trial to dismantle components of cognitive processing therapy for posttraumatic stress disorder in female victims of interpersonal violence. J Consult Clin Psychol. 2008;76(2):243-258. doi:10.1037/0022-006X.76.2.243
    1. Resick PA, Wachen JS, Dondanville KA, et al. ; STRONG STAR Consortium . Variable-length cognitive processing therapy for posttraumatic stress disorder in active duty military: outcomes and predictors. Behav Res Ther. 2021;141:103846. doi:10.1016/j.brat.2021.103846
    1. Schulz KF, Altman DG, Moher D; CONSORT Group . CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010;11:32. doi:10.1186/1745-6215-11-32
    1. Peterson AL, Roache JD, Raj J, Young-McCaughan S; STRONG STAR Consortium . The need for expanded monitoring of adverse events in behavioral health clinical trials. Contemp Clin Trials. 2013;34(1):152-154. doi:10.1016/j.cct.2012.10.009
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association; 2013.
    1. Weathers FW, Bovin MJ, Lee DJ, et al. . The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383-395. doi:10.1037/pas0000486
    1. Sloan DM, Marx BP, Resick PA, et al. ; STRONG STAR Consortium . Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: a noninferiority trial. Contemp Clin Trials Commun. 2019;17:100507. doi:10.1016/j.conctc.2019.100507
    1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association; 1994.
    1. Schnurr PP, Friedman MJ, Foy DW, et al. . Randomized trial of trauma-focused group therapy for posttraumatic stress disorder: results from a department of veterans affairs cooperative study. Arch Gen Psychiatry. 2003;60(5):481-489. doi:10.1001/archpsyc.60.5.481
    1. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Erlbaum; 1988.
    1. Markowitz JC, Petkova E, Neria Y, et al. . Is exposure necessary? a randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatry. 2015;172(5):430-440. doi:10.1176/appi.ajp.2014.14070908
    1. Morland LA, Mackintosh MA, Rosen CS, et al. . Telemedicine versus in-person delivery of cognitive processing therapy for women with posttraumatic stress disorder: a randomized noninferiority trial. Depress Anxiety. 2015;32(11):811-820. doi:10.1002/da.22397
    1. Ranganathan P, Pramesh CS, Aggarwal R. Common pitfalls in statistical analysis: intention-to-treat versus per-protocol analysis. Perspect Clin Res. 2016;7(3):144-146. doi:10.4103/2229-3485.184823
    1. Matilde Sanchez M, Chen X. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat. Stat Med. 2006;25(7):1169-1181. doi:10.1002/sim.2244
    1. Galovski TE, Blain LM, Mott JM, Elwood L, Houle T. Manualized therapy for PTSD: flexing the structure of cognitive processing therapy. J Consult Clin Psychol. 2012;80(6):968-981. doi:10.1037/a0030600
    1. Nacasch N, Huppert JD, Su YJ, et al. . Are 60-minute prolonged exposure sessions with 20-minute imaginal exposure to traumatic memories sufficient to successfully treat PTSD? a randomized noninferiority clinical trial. Behav Ther. 2015;46(3):328-341. doi:10.1016/j.beth.2014.12.002
    1. Institute of Medicine; Committee on the Assessment of Ongoing Efforts in the Treatment of Posttraumatic Stress Disorder; Board on the Health of Select Populations . Treatment for Posttraumatic Stress Disorder in Military and Veteran Populations: Final Assessment. National Academies Press; 2014.
    1. Neria Y. Functional neuroimaging in PTSD: from discovery of underlying mechanisms to addressing diagnostic heterogeneity. Am J Psychiatry. 2021;178(2):128-135. doi:10.1176/appi.ajp.2020.20121727
    1. Gutner CA, Gallagher MW, Baker AS, Sloan DM, Resick PA. Time course of treatment dropout in cognitive-behavioral therapies for posttraumatic stress disorder. Psychol Trauma. 2016;8(1):115-121. doi:10.1037/tra0000062
    1. Wachen JS, Dondanville KA, Evans WR, Morris L, Cole A. Adjusting the timeframe of evidence-based therapies for PTSD-massed treatments. Curr Treat Options Psych. 2019;6:107–118. doi:10.1007/s40501-019-00169-9

Source: PubMed

3
Suscribir